Hester Biosciences Dividends and Buybacks
Dividend criteria checks 4/6
Hester Biosciences is a dividend paying company with a current yield of 0.26% that is well covered by earnings.
Key information
0.3%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 0.3% |
| Dividend Growth | -5.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹6.000 |
| Payout ratio | 27% |
Recent dividend and buyback updates
Recent updates
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23
What Hester Biosciences Limited's (NSE:HESTERBIO) 26% Share Price Gain Is Not Telling You
Jul 27Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price
Jun 12Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00
Aug 01Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?
Mar 03Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?
Feb 13What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?
Jan 26Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11
Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 25Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?
Nov 10If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns
Oct 26What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Oct 05Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?
Sep 14These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?
Jul 07Stability and Growth of Payments
Fetching dividends data
Stable Dividend: HESTERBIO's dividend payments have been volatile in the past 10 years.
Growing Dividend: HESTERBIO's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Hester Biosciences Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (HESTERBIO) | 0.3% |
| Market Bottom 25% (IN) | 0.2% |
| Market Top 25% (IN) | 1.1% |
| Industry Average (Biotechs) | 1.2% |
| Analyst forecast (HESTERBIO) (up to 3 years) | 0.3% |
Notable Dividend: HESTERBIO's dividend (0.26%) is higher than the bottom 25% of dividend payers in the Indian market (0.24%).
High Dividend: HESTERBIO's dividend (0.26%) is low compared to the top 25% of dividend payers in the Indian market (1.14%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (27%), HESTERBIO's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (11.8%), HESTERBIO's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 01:14 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hester Biosciences Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vaishali Kumar Parkar | BOB Capital Markets Ltd. |
| Kameswari V. S. Chavali | FirstCall Research |
| Siddhant Khandekar | ICICIdirect.com |